Podcast

  • EPISODE 15- Addressing The Overlooked AMR Problem
    05.24.2022

    This episode of Making Medicine features Dr. Henry Skinner, CEO of the AMR Action Fund, who discusses the urgency of finding solutions for AMR and how the fund aims to help.

  • EPISODE 14- Pro-Patient Reforms: The Outlook for 2022
    04.19.2022

    In this episode, Making Medicine Host John Stanford is featured as a guest, as he discusses the policy outlook for 2022 with Ashlyn Roberts, our Coalition Manager.

  • EPISODE 13- How Better Data Fosters Health Equity
    04.05.2022

    In this episode, we interview Kirsten Axelsen on the importance of better representation in clinical trials.

  • EPISODE 12- Winning the Drug Development Relay Race
    02.11.2022

    In this episode, we interview Johannes Fruehauf on how drug development is similar to a relay race, and investment into a drug development ecosystem.

  • EPISODE 11- New Modalities: The Future of Drug Development
    12.21.2021

    In this episode, we interview Jean-Francois Formela, Partner at Atlas Venture, about what brought him to Washington and his views on the government’s role in drug development.

  • EPISODE 10- The Investor’s Paradox, Drug Development, & Price Controls
    11.02.2021

    This episode features Peter Kolchinsky, Managing Partner at RA Capital Management, on the state of drug development and the investor's paradox.

  • EPISODE 9- MIT Takeover: A MedTech-VC Partnership Working to Reduce Parkinson’s Tremors
    10.19.2021

    This episode is an MIT takeover, hosted by guest Lindsay Androski Founder, President, and CEO at Roivant Social Ventures and President, Board Member at Incubate Coalition, who discuss wearable solutions for Parkinson's Disease tremors.

  • EPISODE 8- Venture Capital Investors: The Underwriters of Innovation
    09.28.2021

    In this episode, we interview three guests about a collaboration story that represents the best of a healthy healthcare ecosystem.

  • EPISODE 7- The Hidden Cost of Price Control Policies
    09.21.2021

    In this episode, we interview Kirsten Axelsen, Senior Advisor at Charles Rivers Associates, about what would change in biopharma if price controls were implemented.

  • EPISODE 6- You Cannot Make Medicine Alone: Relationships & Mentoring
    07.27.2021

    In this episode, we interview Imran Nasrullah, Vice President & Head, Open Innovation Center North America - East at Bayer Pharmaceuticals, about strengthening relationships within the biotech ecosystem.

  • EPISODE 5- Improving the Standard of Care with Patients in Mind
    07.13.2021

    In this episode, we interview Gaurav Gupta and Hugo Beekman, Co-Founders of Ascendant BioCapital, to discuss their organization and how they’re focusing on drugs that truly make a difference for patients.

  • EPISODE 4- The Truth About Pharmaceuticals
    06.29.2021

    In this episode, we interview Ravi Mehrotra, Thought Leader and former Senior Managing Director of Biotechnology Equity Research at Evercore ISI on the drug pricing debate, misconceptions about the pharmaceutical industry, and HR 3